Gemcitabine in Ovarian Cancer

NCT00191334 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: gemcitabine
DRUG: cisplatin

Sponsor

Eli Lilly and Company